ERBB2 and breast carcinoma: TNBC, a specific subtype of breast cancer characterized by lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), makes up approximately 15% of all breast cancers [37].